Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
Aims: Observational studies of various dose levels of direct oral anticoagulants (DOACs) for patients with atrial fibrillation (AF) found that a high proportion of patients received a dose lower than the target dose tested in randomized controlled trials. There is a need to compare low-dose DOACs wi...
Saved in:
Main Authors: | Sylvie Perreault (Author), Alice Dragomir (Author), Robert Côté (Author), Aurélie Lenglet (Author), Simon de Denus (Author), Marc Dorais (Author), Brian White-Guay (Author), James Brophy (Author), Mireille E. Schnitzer (Author), Marie-Pierre Dubé (Author), Jean-Claude Tardif (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
by: Aurélie Lenglet, et al.
Published: (2022) -
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study
by: Maxime Meloche, et al.
Published: (2022) -
Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure
by: Imad Kassem, et al.
Published: (2021) -
An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites
by: Marc‐Olivier Pilon, et al.
Published: (2022) -
Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation
by: Caroline Brais, et al.
Published: (2017)